Glatiramer Subcutaneous and Lispro-PFC
Determining the interaction of Glatiramer Subcutaneous and Lispro-PFC and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glatiramer Subcutaneous-Lithane
- Glatiramer Subcutaneous-Lithium
- Glatiramer Subcutaneous-Lithium Capsules
- Glatiramer Subcutaneous-Lithium Capsules and Tablets
- Glatiramer Subcutaneous-Lithium Carbonate
- Glatiramer Subcutaneous-Lithium Carbonate ER Tablets
- Lispro-PFC-Glatopa
- Lispro-PFC-Glatopa injection
- Lispro-PFC-Glecaprevir and pibrentasvir
- Lispro-PFC-Gleevec
- Lispro-PFC-Glenmax PEB DM
- Lispro-PFC-Glenmax PEB DM FORTE